pharmacie et médicaments – Doliprane et souveraineté industrielle

This written question concerns the industrial sovereignty of France and the European Union in the pharmaceutical sector, specifically regarding the production of essential medicines like Doliprane. It seeks to understand the current state of industrial capacity and potential vulnerabilities, and what measures can be taken to ensure a stable supply of medicines.